IPP Bureau
Zydus Lifesciences reports Q1 FY26 net profit at Rs. 1,466.8 Cr
By IPP Bureau - August 13, 2025
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Pfizer launches 20-valent Pneumococcal Conjugate Vaccine for adults in India
By IPP Bureau - August 12, 2025
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
.jpg "Briefs: Nectar Lifesciences, Cipla and Marksans Pharma")
Briefs: Nectar Lifesciences, Cipla and Marksans Pharma
By IPP Bureau - August 12, 2025
Marksans Pharma gets USFDA nod for acid reflux drug
Glenmark Pharmaceuticals reached $37.75 million settlement in antitrust litigation in US
By IPP Bureau - August 12, 2025
Glenmark USA is named in multiple antitrust and consumer protection lawsuits, including class actions, consolidated in the Eastern District of Pennsylvania, U.S
Centrient Pharmaceuticals joins UNGC
By IPP Bureau - August 12, 2025
Reinforcing commitment to ethical and sustainable growth
Sartorius and Nanotein Technologies partner to advance cell therapy manufacturing
By IPP Bureau - August 12, 2025
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Asian Institute of Nephrology & Urology expands hospital in Banjara Hills, Hyderabad
By IPP Bureau - August 12, 2025
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Sandoz launches renewable energy partnership
By IPP Bureau - August 12, 2025
The agreement complements other PPAs for Sandoz production sites globally
Boehringer’s lung cancer medicine gets FDA approval
By IPP Bureau - August 12, 2025
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
Gland Pharma gets approval for Norepinephrine Bitartrate in 5% Dextrose injection bags
By IPP Bureau - August 12, 2025
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
Lupin partners with Sadoz to commercialise Ranibizumab biosimilar
By IPP Bureau - August 12, 2025
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Gland Pharma receives FDA approval for Cangrelor for Injection 50 mg/vial
By IPP Bureau - August 12, 2025
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
Cohance to invest $10 million to expand cGMP bioconjugation capabilities in US
By IPP Bureau - August 12, 2025
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad
By IPP Bureau - August 12, 2025
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Dr. Jitendra Singh inaugurates animal stem cell BioBank and laboratory at NIAB, Hyderabad
By IPP Bureau - August 11, 2025
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
